Implantica AG (IMP-A-SDB.ST)
SEK 37.65
(2.45%)
SEK 37.65
(2.45%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 129.95 Million EUR | -12.44% |
| 2022 | 148.4 Million EUR | -9.03% |
| 2021 | 163.13 Million EUR | 39.88% |
| 2020 | 116.61 Million EUR | 492.73% |
| 2019 | 19.67 Million EUR | 6.6% |
| 2018 | 18.45 Million EUR | 38.16% |
| 2017 | 13.35 Million EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 122.12 Million EUR | -6.02% |
| 2024 Q2 | 116 Million EUR | -5.02% |
| 2023 Q1 | 142.47 Million EUR | -4.0% |
| 2023 Q3 | 135.43 Million EUR | -2.78% |
| 2023 FY | 129.95 Million EUR | -12.44% |
| 2023 Q4 | 129.95 Million EUR | -4.05% |
| 2023 Q2 | 139.29 Million EUR | -2.23% |
| 2022 Q1 | 159.69 Million EUR | -2.11% |
| 2022 Q2 | 157.48 Million EUR | -1.38% |
| 2022 Q3 | 156.68 Million EUR | -0.51% |
| 2022 Q4 | 148.4 Million EUR | -5.28% |
| 2022 FY | 148.4 Million EUR | -9.03% |
| 2021 Q3 | 164.69 Million EUR | -2.41% |
| 2021 Q1 | 113.73 Million EUR | -2.48% |
| 2021 Q2 | 168.75 Million EUR | 48.38% |
| 2021 FY | 163.13 Million EUR | 39.88% |
| 2021 Q4 | 163.13 Million EUR | -0.95% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q3 | 109.91 Million EUR | 468.01% |
| 2020 Q2 | 19.35 Million EUR | 0.0% |
| 2020 FY | 116.61 Million EUR | 492.73% |
| 2020 Q4 | 116.61 Million EUR | 6.1% |
| 2019 FY | 19.67 Million EUR | 6.6% |
| 2019 Q4 | 19.67 Million EUR | 0.0% |
| 2018 FY | 18.45 Million EUR | 38.16% |
| 2017 FY | 13.35 Million EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -106.652% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 96.047% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 96.047% |
| Arcoma AB | 81.96 Million SEK | -58.55% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 80.97% |
| BICO Group AB (publ) | 10.19 Billion SEK | 98.726% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 82.79% |
| CellaVision AB (publ) | 928.71 Million SEK | 86.007% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -125.121% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -491.884% |
| C-Rad AB (publ) | 404 Million SEK | 67.834% |
| Duearity AB (publ) | 15.14 Million SEK | -758.102% |
| Dignitana AB (publ) | 44.83 Million SEK | -189.869% |
| Episurf Medical AB (publ) | 104.3 Million SEK | -24.593% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.764% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | -26.611% |
| Iconovo AB (publ) | 128.07 Million SEK | -1.461% |
| Integrum AB (publ) | 164.85 Million SEK | 21.175% |
| Luxbright AB (publ) | 40.68 Million SEK | -219.395% |
| Mentice AB (publ) | 322.52 Million SEK | 59.708% |
| OssDsign AB (publ) | 356.38 Million SEK | 63.537% |
| Paxman AB (publ) | 167.12 Million SEK | 22.243% |
| Promimic AB (publ) | 92.87 Million SEK | -39.92% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -232.815% |
| SciBase Holding AB (publ) | 64.33 Million SEK | -101.994% |
| ScandiDos AB (publ) | 81.47 Million SEK | -59.502% |
| Sectra AB (publ) | 3.21 Billion SEK | 95.953% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 87.185% |
| Senzime AB (publ) | 433.54 Million SEK | 70.026% |
| SpectraCure AB (publ) | 144.83 Million SEK | 10.276% |
| Stille AB | 804.89 Million SEK | 83.855% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 99.207% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 94.081% |